Foster City, California

4th April 2019

Disruptive Technologies

 

Description:

This PhUSE SDE will focus on disruptive technologies and methodologies that are beginning to impact pharmaceutical companies now and in the near future, specifically around development operations and biometrics. Attendees will understand and engage in talks discussing successful implementation of emerging technologies within sponsor companies, as well as technology vendors, and any potential impact on the future of programming roles in these areas. This will help inform strategic planning around human resources and systems, and also shed light on potential future opportunities.

 

Presentations:

Leveraging SAS for Data Science Applications – Sunil Gupta, Cytel

Automation of the Narrative Section of the Clinical Study Report for Oncology Studies – Geoffrey Mann, JMP

A Disruptive Approach in Developing and Delivering Therapies: Marrying Connected Platforms and Data Science to Change the Paradigm of RWE Generation – Deepti Jaggi, Clinakos

Disrupt Data Management in Our New Multi Data Source World Using Real-world Evidence & Patient-centricity Initiatives and Machine Learning Techniques – Greg Jones, Oracle Health Sciences

There’s a Snake in My Group: Exploring Python’s Capabilities – Kevin Miller, Gilead Sciences

Using R to Generate SDTM/ADaM Datasets – Prasanna Murugesan, AstraZeneca

Jupyter, OData and RESTful APIs: An Interactive Computing Environment for Indexed Clinical and Biomarker Data – Suresh Madhavan, PointCross

 

View the event brochure.

 

Sponsors:

  

    

 

 

 

Photos of the day:

 

Chair, DJ Chhatre, Gilead Sciences, kicked off the Foster City SDE.

Amy Carron, Executive Director Statistical Programming, Gilead Sciences, welcomed the attendees.

Sunil Gupta, Cytel's Director Statistical Programming, presented on the scope and usefulness of SAS metadata.

Selfie-time with the PhUSE Americas Director and SDE Chair, DJ Chhatre.

Geoffrey Mannn, Principle Product Manager, JMP, showed the automation of the narrative section of the CSR for oncology trials.

   Deepti Jaggi, President and Chief Medical Officaer, Clinakos, talked about marrying connected platforns and data science to change the paradigm of real-world evidence generation.

Greg Jones, Oracle Health Sciences, talked about the disruption of data management in our new multi data source world using real-world evidence & patient centricity initiatives, and machine learning techniques.

Kevin Miller, Gilead Sciences, gave a talk about Python.

Chris Hurley, PhUSE Americas Director, provided an update on PhUSE.

Another selfie! Chris Hurley with the CEO of PointCross, Suresh Madhaven.

Suresh Madhaven, CEO PointCross, talked about an interactive computing environment for indexed clinical and biomarker data.

Other photos of the day:

We appreciate all of the work that goes on behind the scenes to support our event.

 

 

 

Thinking of joining PhUSE?

Already a member but not sure how you can benefit?

PhUSE is an expanding, global society with a membership of more than 8,000 clinical data scientists. It requires a large pool of resources to help with its running so offers many opportunities for members to become involved. Whether it's chairing a conference, presenting at an event, leading a working group or contributing to the quarterly newsletter, we are always keen to hear from volunteers.

Find Out More